CDI Ingénieur Process F/H at Eli Lilly and Company

Fegersheim, Grand Est, France

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Titulaire d’un diplôme d’Ingénieur généraliste ou mécanique issu d’une grande école (type ENSAM, Ecole Centrale, INSA …)
Débutant, ou première expérience professionnelle en industrie
Solides connaissances techniques en mécanique, électricité, automatisation et robotique
Maîtrise de l’anglais (niveau B2 souhaité)

Responsibilities

Coordonner des actions correctives pour sécuriser et garantir la continuité des opérations de production en cas d’évènements
Investiguer la non-conformité des systèmes procédés à l’aide d’outils méthodologiques (RCA, FMEA)
Préparer et exécuter la documentation de qualification (DQ, IQ/OQ, etc.)
Préparer et suivre l’essai, analyser et traiter les données issues de l’essai
Proposer des actions pour accroître la productivité et le niveau de qualité
Mettre en place et gérer des actions de fiabilisation pour maintenir les installations en conformité avec le référentiel qualité et avec les standards d’ingénierie
Rédiger, coordonner et mener des études/essais dans le cadre de projets, d’actions ou d’initiatives transverses
Former le personnel à de nouvelles pratiques à l’aide de modules de formation

Skills

Process Engineering

RCA

FMEA

Pharmaceutical Manufacturing

Corrective Actions

Non-Conformance Investigation

Equipment Qualification

Production Support

Quality Assurance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free